These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 12777264)

  • 21. Parent-Reported Health Consequences and Relationship to Expenditures in Children with ADHD.
    deJong NA; Williams CS; Thomas KC
    Matern Child Health J; 2016 Apr; 20(4):915-24. PubMed ID: 26754346
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Race/ethnicity and insurance status as factors associated with ADHD treatment patterns.
    Stevens J; Harman JS; Kelleher KJ
    J Child Adolesc Psychopharmacol; 2005 Feb; 15(1):88-96. PubMed ID: 15741790
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Outpatient Visits and Medication Prescribing for US Children With Mental Health Conditions.
    Anderson LE; Chen ML; Perrin JM; Van Cleave J
    Pediatrics; 2015 Nov; 136(5):e1178-85. PubMed ID: 26459647
    [TBL] [Abstract][Full Text] [Related]  

  • 24. National trends in the outpatient treatment of depression.
    Olfson M; Marcus SC; Druss B; Elinson L; Tanielian T; Pincus HA
    JAMA; 2002 Jan; 287(2):203-9. PubMed ID: 11779262
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ADHD service use patterns in youth.
    Leslie LK; Wolraich ML
    J Pediatr Psychol; 2007 Jul; 32(6):695-710. PubMed ID: 17556401
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pharmacotherapy with atomoxetine for US children and adolescents.
    Bhatara VS; Aparasu RR
    Ann Clin Psychiatry; 2007; 19(3):175-80. PubMed ID: 17729019
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnosis and treatment of adult attention-deficit/hyperactivity disorder at US ambulatory care visits from 1996 to 2003.
    Sankaranarayanan J; Puumala SE; Kratochvil CJ
    Curr Med Res Opin; 2006 Aug; 22(8):1475-91. PubMed ID: 16870073
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnosis of attention-deficit/hyperactivity disorder and use of psychotropic medication in very young children.
    Rappley MD; Mullan PB; Alvarez FJ; Eneli IU; Wang J; Gardiner JC
    Arch Pediatr Adolesc Med; 1999 Oct; 153(10):1039-45. PubMed ID: 10520611
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Period prevalence of concomitant psychotropic medication usage among children and adolescents with attention-deficit/hyperactivity disorder during 2009.
    Betts KA; Sikirica V; Hodgkins P; Zhou Z; Xie J; DeLeon A; Erder MH; Wu EQ
    J Child Adolesc Psychopharmacol; 2014 Jun; 24(5):260-8. PubMed ID: 24839998
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of attention-deficit hyperactivity disorder by different physician specialties.
    Zarin DA; Tanielian TL; Suarez AP; Marcus SC
    Psychiatr Serv; 1998 Feb; 49(2):171. PubMed ID: 9574998
    [No Abstract]   [Full Text] [Related]  

  • 31. Trends in Treatment and Spending for Patients Receiving Outpatient Treatment of Depression in the United States, 1998-2015.
    Hockenberry JM; Joski P; Yarbrough C; Druss BG
    JAMA Psychiatry; 2019 Aug; 76(8):810-817. PubMed ID: 31017627
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Psychiatric inpatient, outpatient, and medication utilization and costs among privately insured youths, 1997-2000.
    Martin A; Leslie D
    Am J Psychiatry; 2003 Apr; 160(4):757-64. PubMed ID: 12668366
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Attention-deficit/hyperactivity disorder in school-aged children: association with maternal mental health and use of health care resources.
    Lesesne CA; Visser SN; White CP
    Pediatrics; 2003 May; 111(5 Pt 2):1232-7. PubMed ID: 12728144
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Are stimulants overprescribed? Treatment of ADHD in four U.S. communities.
    Jensen PS; Kettle L; Roper MT; Sloan MT; Dulcan MK; Hoven C; Bird HR; Bauermeister JJ; Payne JD
    J Am Acad Child Adolesc Psychiatry; 1999 Jul; 38(7):797-804. PubMed ID: 10405496
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sociodemographic and economic comparisons of children prescribed longer-acting versus short-acting stimulant medications for attention deficit hyperactivity disorder.
    Stevens J; Harman JS; Kelleher KJ
    J Behav Health Serv Res; 2005; 32(4):430-7. PubMed ID: 16215451
    [TBL] [Abstract][Full Text] [Related]  

  • 36. ADHD and health services utilization in the national health interview survey.
    Cuffe SP; Moore CG; McKeown R
    J Atten Disord; 2009 Jan; 12(4):330-40. PubMed ID: 19095891
    [TBL] [Abstract][Full Text] [Related]  

  • 37. National trends in concomitant psychotropic medication with stimulants in pediatric visits: practice versus knowledge.
    Bhatara V; Feil M; Hoagwood K; Vitiello B; Zima B
    J Atten Disord; 2004 May; 7(4):217-26. PubMed ID: 15487478
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Impact of 3-tier formularies on drug treatment of attention-deficit/hyperactivity disorder in children.
    Huskamp HA; Deverka PA; Epstein AM; Epstein RS; McGuigan KA; Muriel AC; Frank RG
    Arch Gen Psychiatry; 2005 Apr; 62(4):435-41. PubMed ID: 15809411
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Outpatient rehabilitation utilization and medical expenses in children aged 0-7 years with ADHD: analyses of population-based national health insurance data.
    Lin JD; Chen YH; Lin LP
    Res Dev Disabil; 2013 Jul; 34(7):2127-32. PubMed ID: 23643766
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Economic Burden of Attention-Deficit/Hyperactivity Disorder among Pediatric Patients in the United States.
    Gupte-Singh K; Singh RR; Lawson KA
    Value Health; 2017 Apr; 20(4):602-609. PubMed ID: 28408002
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.